These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15476952)

  • 1. Structure-activity relationships and structural conformation of a novel urotensin II-related peptide.
    Chatenet D; Dubessy C; Leprince J; Boularan C; Carlier L; Ségalas-Milazzo I; Guilhaudis L; Oulyadi H; Davoust D; Scalbert E; Pfeiffer B; Renard P; Tonon MC; Lihrmann I; Pacaud P; Vaudry H
    Peptides; 2004 Oct; 25(10):1819-30. PubMed ID: 15476952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes.
    Diallo M; Jarry M; Desrues L; Castel H; Chatenet D; Leprince J; Vaudry H; Tonon MC; Gandolfo P
    Peptides; 2008 May; 29(5):813-9. PubMed ID: 18082287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain.
    Sugo T; Murakami Y; Shimomura Y; Harada M; Abe M; Ishibashi Y; Kitada C; Miyajima N; Suzuki N; Mori M; Fujino M
    Biochem Biophys Res Commun; 2003 Oct; 310(3):860-8. PubMed ID: 14550283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urotensin II-related peptide, the endogenous ligand for the urotensin II receptor in the rat brain.
    Mori M; Fujino M
    Peptides; 2004 Oct; 25(10):1815-8. PubMed ID: 15476951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction.
    Labarrère P; Chatenet D; Leprince J; Marionneau C; Loirand G; Tonon MC; Dubessy C; Scalbert E; Pfeiffer B; Renard P; Calas B; Pacaud P; Vaudry H
    J Enzyme Inhib Med Chem; 2003 Apr; 18(2):77-88. PubMed ID: 12943190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships of urotensin II and URP.
    Leprince J; Chatenet D; Dubessy C; Fournier A; Pfeiffer B; Scalbert E; Renard P; Pacaud P; Oulyadi H; Ségalas-Milazzo I; Guilhaudis L; Davoust D; Tonon MC; Vaudry H
    Peptides; 2008 May; 29(5):658-73. PubMed ID: 17931747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Another ligand fishing for G protein-coupled receptor 14. Discovery of urotensin II-related peptide in the rat brain.
    Sugo T; Mori M
    Peptides; 2008 May; 29(5):809-12. PubMed ID: 17628210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics.
    Wei X; Diarra S; Douchez A; Cunico Dallagnol JC; Hébert TE; Chatenet D; Lubell WD
    J Med Chem; 2023 Oct; 66(20):14241-14262. PubMed ID: 37800680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist.
    Chatenet D; Dubessy C; Boularan C; Scalbert E; Pfeiffer B; Renard P; Lihrmann I; Pacaud P; Tonon MC; Vaudry H; Leprince J
    J Med Chem; 2006 Nov; 49(24):7234-8. PubMed ID: 17125276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists.
    Chatenet D; Folch B; Feytens D; Létourneau M; Tourwé D; Doucet N; Fournier A
    J Med Chem; 2013 Dec; 56(23):9612-22. PubMed ID: 24251366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: insight into UII and URP receptor activation.
    Chatenet D; Létourneau M; Nguyen QT; Doan ND; Dupuis J; Fournier A
    Br J Pharmacol; 2013 Feb; 168(4):807-21. PubMed ID: 22994258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, urotensin II-related peptide, and their receptor: from structure to function.
    Vaudry H; Leprince J; Chatenet D; Fournier A; Lambert DG; Le Mével JC; Ohlstein EH; Schwertani A; Tostivint H; Vaudry D
    Pharmacol Rev; 2015; 67(1):214-58. PubMed ID: 25535277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insight into the role of urotensin II-related peptide tyrosine residue in UT activation.
    Billard E; Létourneau M; Hébert TE; Chatenet D
    Biochem Pharmacol; 2017 Nov; 144():100-107. PubMed ID: 28784291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urotensin II((4-11)) Azasulfuryl Peptides: Synthesis and Biological Activity.
    Merlino F; Yousif AM; Billard É; Dufour-Gallant J; Turcotte S; Grieco P; Chatenet D; Lubell WD
    J Med Chem; 2016 May; 59(10):4740-52. PubMed ID: 27140209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue.
    Billard E; Hébert TE; Chatenet D
    J Med Chem; 2018 Oct; 61(19):8707-8716. PubMed ID: 30183282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent cardiovascular effects of homologous urotensin II (UII)-related peptide and UII in unanesthetized eels after peripheral and central injections.
    Nobata S; Donald JA; Balment RJ; Takei Y
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R437-46. PubMed ID: 21123764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation.
    Jarry M; Diallo M; Lecointre C; Desrues L; Tokay T; Chatenet D; Leprince J; Rossi O; Vaudry H; Tonon MC; Prézeau L; Castel H; Gandolfo P
    Biochem J; 2010 Apr; 428(1):113-24. PubMed ID: 20192922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the origin of the biased agonism associated with the urotensin II receptor activation.
    Brancaccio D; Merlino F; Limatola A; Yousif AM; Gomez-Monterrey I; Campiglia P; Novellino E; Grieco P; Carotenuto A
    J Pept Sci; 2015 May; 21(5):392-9. PubMed ID: 25694247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide.
    Carotenuto A; Auriemma L; Merlino F; Limatola A; Campiglia P; Gomez-Monterrey I; di Villa Bianca Rd; Brancaccio D; Santicioli P; Meini S; Maggi CA; Novellino E; Grieco P
    J Pept Sci; 2013 May; 19(5):293-300. PubMed ID: 23526702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Peptides; 2008 May; 29(5):770-7. PubMed ID: 17900760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.